Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lancranjan

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Endocrinological Investigation|April 1, 1987
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemiaE Ciccarelli, E Ghigo, E Mazza, et al.
Acta Neurochirurgica|January 1, 1989
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinomaG Hildebrandt, J Zierski, P Christophis, et al.
International Journal of Neurology|January 1, 1979
Neurotransmitters--control of growth hormone (GH) and prolactin (PRL) secretion: the adrenergic and serotoninergic modulation of GH and PRL in manI Lancranjan, E Ohnhaus, P Marbach, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1977
Hormonal mechanism of milk secretion in the newbornJ Hiba, E D Pozo, A Genazzani, et al.
European Journal of Endocrinology|October 7, 2000
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatmentA Kaal, H Orskov, S Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegalyP M Stewart, K F Kane, S E Stewart, et al.
Clinical Endocrinology|August 1, 1990
Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)G Schettini, G Lombardi, B Merola, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range studyA K Fløgstad, J Halse, T Haldorsen, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1991
Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridizationK Kovacs, L Stefaneanu, E Horvath, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptineM Montini, G Pagani, D Gianola, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Endocrinological Investigation|April 1, 1987
Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemiaE Ciccarelli, E Ghigo, E Mazza, et al.
Acta Neurochirurgica|January 1, 1989
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinomaG Hildebrandt, J Zierski, P Christophis, et al.
International Journal of Neurology|January 1, 1979
Neurotransmitters--control of growth hormone (GH) and prolactin (PRL) secretion: the adrenergic and serotoninergic modulation of GH and PRL in manI Lancranjan, E Ohnhaus, P Marbach, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1977
Hormonal mechanism of milk secretion in the newbornJ Hiba, E D Pozo, A Genazzani, et al.
European Journal of Endocrinology|October 7, 2000
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatmentA Kaal, H Orskov, S Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1995
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegalyP M Stewart, K F Kane, S E Stewart, et al.
Clinical Endocrinology|August 1, 1990
Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR)G Schettini, G Lombardi, B Merola, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
Sandostatin LAR in acromegalic patients: a dose-range studyA K Fløgstad, J Halse, T Haldorsen, et al.
Virchows Archiv. A, Pathological Anatomy and Histopathology|January 1, 1991
Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphological study including immunocytochemistry, electron microscopy and in situ hybridizationK Kovacs, L Stefaneanu, E Horvath, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1986
Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptineM Montini, G Pagani, D Gianola, et al.
Pageof 8